Stroke therapy: the potential of amniotic fluid-derived stem cells.

about

Multiparity improves outcomes after cerebral ischemia in female mice despite features of increased metabovascular risk.

P2860

Q38711384-2098D0EB-D0F4-4E1A-8C63-BB142009E13F

P2860

Stroke therapy: the potential of amniotic fluid-derived stem cells.

Item

http://www.wikidata.org/entity/Q36079327

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Stroke therapy: the potential of amniotic fluid-derived stem cells.

@ast

Stroke therapy: the potential of amniotic fluid-derived stem cells.

@en

type

Item

label

Stroke therapy: the potential of amniotic fluid-derived stem cells.

@ast

Stroke therapy: the potential of amniotic fluid-derived stem cells.

@en

prefLabel

Stroke therapy: the potential of amniotic fluid-derived stem cells.

@ast

Stroke therapy: the potential of amniotic fluid-derived stem cells.

@en

P1476

Stroke therapy: the potential of amniotic fluid-derived stem cells.

@en

P2093

Cesar V Borlongan

http://www.w3.org/2001/XMLSchema#string

Christopher Lawton

http://www.w3.org/2001/XMLSchema#string

Hung Nguyen

http://www.w3.org/2001/XMLSchema#string

Jaclyn Hoover

http://www.w3.org/2001/XMLSchema#string

Stephanny Reyes

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombolysis for acute ischaemic stroke

Cell-based therapy for ischemic stroke

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

Characterization of amniotic stem cells.

Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke.

Levels of CD105(+) cells increase and cell proliferation decreases during S-phase arrest of amniotic fluid cells in long-term culture

Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats.

Isolation of amniotic stem cell lines with potential for therapy.

Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.

Immune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational age

P304

321-326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FNL.15.19

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maya N Elias

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26401122

http://www.w3.org/2001/XMLSchema#string

P932

4577242

http://www.w3.org/2001/XMLSchema#string

Stroke therapy: the potential of amniotic fluid-derived stem cells.

about

P2860

P2860

Stroke therapy: the potential of amniotic fluid-derived stem cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932